Evidence map›Paper›PMID 42624847›Full record

ArticleNature communications2026

Author Correction: Specific oncogene activation of the cell of origin in mucosal melanoma.

Swathy Babu, Jiajia Chen, Chloé S Baron, Kaiwen Sun, Emily Robitschek, Alicia M McConnell, Constance Wu, Aikaterini Dedeilia, Moshe Sade-Feldman, Rodsy Modhurima and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Swathy BabuDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0612-9484
Jiajia ChenDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5378-6284
Chloé S BaronStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8351-4768
Kaiwen SunDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Emily RobitschekDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Alicia M McConnellStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.
Constance WuStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.
Aikaterini DedeiliaMassachusetts General Hospital (MGH) Department of Surgery, MGH Krantz Center for Cancer Research, Boston, MA, USA.
Moshe Sade-FeldmanMassachusetts General Hospital (MGH) Department of Surgery, MGH Krantz Center for Cancer Research, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0022-0287
Rodsy ModhurimaStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.
Michael P ManosDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0841-207X
Kevin Y ChenStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.
Anna M CoxDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Calvin G LudwigStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1938-4273
Manolis KellisBroad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-7113-9630
Elizabeth I BuchbinderDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nir HacohenMassachusetts General Hospital (MGH) Department of Surgery, MGH Krantz Center for Cancer Research, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2349-2656
Jiekun YangBroad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, USA.
Genevieve M BolandMassachusetts General Hospital (MGH) Department of Surgery, MGH Krantz Center for Cancer Research, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7522-6173
Brian J AbrahamDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0001-8085-3027
David LiuDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0346-5033
Leonard I ZonStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, USA. leonard.zon@enders.tch.harvard.edu.
Megan L InscoDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Megan_Insco@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-6078-6506

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42624847
PMCPMC13493764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.